Gunderson Dettmer represented Enveda Biosciences on the deal.Enveda Biosciences, a drug discovery and development company, announced the additional $51 million equity financing, adding to the $68 million…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now